Infographic: The Diabetes Pipeline

A recent report examined the products and projects targeting diabetes and diabetes-related complications are in the current biopharmaceutical pipeline. Our infographic details the key findings.

Related Content:

Diabetes

How State Substitution Laws Shape Insulin Biosimilar Adoption

FDA Approves First Insulin Aspart Biosimilar

Biosimilars Fuel Price Cuts in European Insulin Glargine Markets